NCT03879694 2026-02-06Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine TumorsRoswell Park Cancer InstitutePhase 1 Completed19 enrolled
NCT03289741 2025-05-09A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus LanreotideMemorial Sloan Kettering Cancer CenterPhase 4 Completed51 enrolled 10 charts